Patent Assignment
Reel/Frame 070551/0095
Release of Security Interest in Patent Collateral
Recorded: 2025-03-05
Pages: 16
Assignor
BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Executed: 2025-02-28
Assignees
BRIDGEBIO PHARMA, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
QED THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
EIDOS THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
ML BIO SOLUTIONS INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
CALCILYTIX THERAPEUTICS INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
ADRENAS THERAPEUTICS INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
PHOENIX TISSUE REPAIR, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
NAVIRE PHARMA, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
VENTHERA, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
MOLECULAR SKIN THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
CANTERO THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
COA THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
PORTAL THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
BRIDGEBIO GENE THERAPY RESEARCH, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
FERRO THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
Covered Properties
(53)
Composition, Process and Apparatus
Collagen 7 and Related Methods
Collagen Iv Binding Assay for the Detection of Collagen Vii
Processes For Preparing AG-10, Its Intermediates, and Salts Thereof
Collagen 7 Compositions and Methods of Using the Same
Methods of Purifying Collagen 7
Compounds and Method of Use
Methods of Treating Ttr Amyloidosis Using AG10
Substituted Heterocyclic Inhibitors of PTPN11
PTPN11 Inhibitors
Formulations of AG10
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
Topical Phosphoinositide 3-Kinase Inhibitors
Compounds and Methods of Use
Methods of Treating Disorders Associated with Castor
Small Molecule Modulators of Pantothenate Kinases
Adeno-Associated Virus Gene Therapy for 21-Hydroxylase Deficiency
Benzoxazinone Compounds as KLK5/7 Dual Inhibitors
Collagen Iv Binding Assay for the Detection of Collagen Vii
Application:
17/141,586 →
Publication:
US 2021/0132091
Substituted Heterocyclic Inhibitors of PTPN11
Triazole Glycolate Oxidase Inhibitors
Methods of Treating Ttr Amyloidosis Using AG10
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
PTPN11 Inhibitors
Formulations of Phosphoinositide 3-Kinase Inhibitors
Application:
17/393,196 →
Publication:
US 2022/0040193
Treatment Methods of Triphenyl Calcilytic Compounds
Application:
17/477,198 →
Publication:
US 2022/0087961
Formulations of AG10
Systems and Methods for Producing Collagen 7 Compositions
Application:
17/598,029 →
Publication:
US 2022/0177546
Methods of Treating Cholangiocarcinoma
Methods of Treating Urinary System Cancers
Application:
17/613,652 →
Publication:
US 2022/0233537
Benzimidazole and Hydrogenated Carbazole Derivatives as GPX4 Inhibitors
Application:
17/638,741 →
Publication:
US 2022/0227716
Pyrido-Indole Analogues as GPX4 Inhibitors
Application:
17/638,744 →
Publication:
US 2022/0227765
Detection of Dystroglycan
Application:
17/679,841 →
Publication:
US 2022/0291236
Processes for Preparing Triazole Glycolate Oxidase Inhibitors
Application:
17/791,482 →
Publication:
US 2023/0129160
Triazole Glycolate Oxidase Inhibitors
Application:
17/843,455 →
Publication:
US 2023/0143491
Compounds and Methods of Use
Application:
18/023,270 →
Publication:
US 2024/0092739
Methods of Treating Disorders Associated with Castor
Application:
18/076,044 →
Publication:
US 2023/0321092
Collagen 7 Compositions and Methods of Using the Same
Application:
18/169,368 →
Publication:
US 2023/0414698
Formulations of Triphenyl Calcilytic Compounds
Methods of Treating Achondroplasia
Application:
18/257,450 →
Publication:
US 2024/0009193
Benzoxazinone Compounds as KLK5/7 Dual Inhibitors
Topical Phosphoinositide 3-Kinase Inhibitors
Methods of Preparing Gene Therapies
Application:
18/319,350 →
Publication:
US 2024/0002812
Gene Therapies for 21-Hydroxylase Deficiency
Application:
18/551,143 →
Publication:
US 2024/0191213
Collagen 7 Protein Replacement Therapy
Application:
63/342,993 →
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application:
63/487,801 →
Methods of Treating Skeletal Dysplasias
Application:
63/488,709 →
Deuterated Infigratinib Compounds
Application:
63/489,168 →
Assays for Alpha-Dystroglycan Glycosylation and Methods for Using Same
Application:
63/490,216 →
Treatment of Hypoparathyroidism Using Triphenyl Calcilytic Compounds
Application:
63/497,693 →
Methods of Treating Skeletal Dysplasias
Application:
63/508,789 →
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application:
63/516,757 →
Methods of Treating Skeletal Disorders
Application:
63/546,133 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2004
From: POPE, BRENT K.; MILLICAN, JERRY D.; GIESSEN, TIMOTHY GLEN VANDE
To: HILL'S PET NUTRITION
Reel/Frame 014978/0776 →
Assignment of Assignor's Interest
Sep 11, 2014
From: VISWANATHAN, MALINI; DE SOUZA, MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 033722/0643 →
Assignment of Assignor's Interest
Aug 30, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 043447/0805 →
Assignment of Assignor's Interest
Sep 13, 2017
From: MAGIL, SHEILA G.
To: LOTUS TISSUE REPAIR INC.
Reel/Frame 043577/0390 →
Assignment of Assignor's Interest
Sep 13, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 043572/0252 →
Assignment of Assignor's Interest
Aug 23, 2018
From: QUINONES-GARCIA, IGOR; GUEY, LIN; LOWE, KRIS; NGUYEN, VINH
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 046682/0823 →
Assignment of Assignor's Interest
Aug 23, 2018
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 046683/0123 →
Assignment of Assignor's Interest
Oct 24, 2018
From: SHIRE HUMAN GENETIC THERAPIES, INC.; LOTUS TISSUE REPAIR, INC.
To: PHOENIX TISSUE REPAIR, INC.
Reel/Frame 047291/0591 →
Assignment of Assignor's Interest
Oct 24, 2018
From: QUINONES-GARCIA, IGOR; SIMEONE, BENJAMIN; LILLIE, RAYMOND; YANG, TING
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 047291/0523 →
Assignment of Assignor's Interest
Mar 22, 2019
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 048671/0933 →
Assignment of Assignor's Interest
Apr 30, 2019
From: KALITA, BISWAJIT; DURAISWAMY, ATHISAYAMANI JEYARAJ
To: JUBILANT BIOSYS LIMITED
Reel/Frame 049041/0034 →
Assignment of Assignor's Interest
Apr 30, 2019
From: JUBILANT BIOSYS LIMITED
To: FERRO THERAPEUTICS, INC
Reel/Frame 049041/0038 →
Assignment of Assignor's Interest
Apr 30, 2019
From: CHEN, RUIHONG; JIANG, CHUN; PANDEY, ANJALI
To: FERRO THERAPEUTICS, INC.
Reel/Frame 049041/0041 →
Assignment of Assignor's Interest
Jul 9, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 049705/0637 →
Assignment of Assignor's Interest
Jul 9, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 049705/0617 →
Assignment of Assignor's Interest
Jul 23, 2019
From: SINHA, UMA; RAO, SATISH
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 049838/0284 →
Assignment of Assignor's Interest
Aug 19, 2019
From: JONES, PHILIP; CZAKO, BARBARA; CARROLL, CHRISTOPHER L.; MANDAL, PIJUS
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 050093/0189 →
Assignment of Assignor's Interest
Oct 2, 2019
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 050608/0913 →
Assignment of Assignor's Interest
Nov 12, 2019
From: JERNELIUS, JESPER; MENNING, MARK MICHAEL
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 050986/0980 →
Assignment of Assignor's Interest
Apr 22, 2020
From: CHAND, POORAN; GUPTA, YOGESH KUMAR; KUMAWAT, RAKESH KUMAR; ALHAMADSHEH, MAMOUN
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 052467/0650 →
Assignment of Assignor's Interest
Aug 7, 2020
From: BOUGNERES, PIERRE; GAO, GUANGPING
To: ADRENAS THERAPEUTICS, INC.
Reel/Frame 053433/0556 →
Assignment of Assignor's Interest
Oct 6, 2020
From: ZAMBONI, ROBERT; REDDY, T. JAGADEESWAR
To: COA THERAPEUTICS, INC.
Reel/Frame 053993/0104 →
Assignment of Assignor's Interest
Oct 6, 2020
From: LEE, RICHARD E.; TANGALLAPALLY, RAJENDRA P.; ROCK, CHARLES O.; JACKOWSKI, SUZANNE
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 053992/0074 →
Assignment of Assignor's Interest
Oct 6, 2020
From: JACKOWSKI, SUZANNE; ROCK, CHARLES O.; LEE, RICHARD E.; SHARMA, LALIT KUMAR
To: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC.
Reel/Frame 053992/0001 →
Assignment of Assignor's Interest
Oct 21, 2020
From: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NAVIRE PHARMA, INC.
Reel/Frame 054130/0519 →